- Stem Cell day 1
STEM CELL SCIENCE AND REGENERATIVE MEDICINES CONGRESS WORLD CONGRESS 2022 EUROPE
“Revolutionizing the way human diseases are treated”
Day 1 - Thursday 6th October 2022
- Recent policies that support clinical application of induced pluripotent stem cell-based regenerative therapies
- How different markets approach the regulation and commercialization of advanced therapies
- Current data on how product effects clinical outcomes
PRODUCT, PROCESS AND MANUFACTURING DEVELOPMENT
- Implications and advances in stem cell therapy (T-Cells, NK Cells, DCs, Vaccines, iPSCs & MSCs)
- Setting global standards for stem cell research and clinical translation
- Use of chip-based microsystems for genomic and proteomic analysis
- Developing nanostructured thin films as biomimetic tissue-engineered platform for cancer research
- Applications of high-throughput cellular microarray platforms in drug discovery, toxicology and stem cell research
- Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening
- Using mouse and human pancreatic organoids to infer resistance to targeted therapy
- Patient-derived organoids as an in vitro model of neuroendocrine tumors
- Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure
- Regulation of ribosome biogenesis and protein synthesis controls germline stem cell differentiation
- Global regulatory developments for clinical stem cell research
- Issues surrounding the authentication and quality of induced pluripotent stem cells
STEM CELL PRODUCT, PROCESS AND MANUFACTURING DEVELOPMENT
- Flow-induced epigenetic mechanisms of endothelial gene expression
- Emerging role of nutri-epigenetics in inflammation and cancer
- Epigenomic annotation of regulatory changes in adult tissue and stem cell based models
- Advancing biomaterials of human origin for tissue engineering
- Bio-inspired 3D microenvironments for stem cell reprogramming
- Implementing oxygen control in chip-based cell and tissue culture systems
Process parameters for the high-scale production alginate-encapsulated stem cells for storage and distribution throughout the cell therapy supply chain
CASE STUDY
- Computational tools for stem cell biology
- Developing an automated robotic factory for novel stem cell therapy production
- Issues of supplying new technologies into highly regulated markets
PANEL DISCUSSION
- Innovative, comprehensive mapping and multiscale analysis of registered trials for stem cell-based regenerative medicine
- Failure mode and effects analysis to reduce risks of errors in the good manufacturing practice production of engineered tissue and cells
- Regulatory requirements in the good manufacturing practice production of an epithelial cell graft for ocular surface reconstruction